(Q34282786)

1 August 2017

title

Effective short term treatment of Paget's disease with oral etidronate (English)

1 reference

1 August 2017

Preston CJ

1

1 reference

1 August 2017

Yates AJ

2

1 reference

1 August 2017

Beneton MN

3

1 reference

1 August 2017

Russell RG

4

1 reference

1 August 2017

Gray RE

5

1 reference

1 August 2017

Smith R

6

1 reference

1 August 2017

Kanis JA

7

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 January 1986

1 reference

1 August 2017

1 reference

1 August 2017

volume

292

1 reference

1 August 2017

issue

6513

1 reference

1 August 2017

page(s)

79-80

1 reference

Focal osteomalacia due to low-dose diphosphonate therapy in Paget's disease

1 August 2017

cites work

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1339104

Intravenous clodronate in the treatment and retreatment of Paget's disease of bone.

6 July 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1339104

Changes in the renal and extrarenal handling of phosphate induced by disodium etidronate (EHDP) in man.

6 July 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1339104

Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans)

6 July 2018

1 reference

12 December 2020

Diphosphonates in Paget's disease

1 reference

12 December 2020

Diphosphonates and inhibition of bone mineralization

1 reference

12 December 2020

Monitoring the treatment of Paget's disease with etidronate

1 reference

12 December 2020

Identifiers

DOI

10.1136/BMJ.292.6513.79

0 references

PMC publication ID

1339104

1 reference

1 August 2017

1 reference